Hepatic fat accumulates silently, and remains reversible for longer than most people are told.
Hepatic fat is a balance of four flows: uptake from circulation (CD36), synthesis in place (lipogenesis) under the sensor restraining it (AMPK), oxidation, and export as lipoprotein (VLDL). Accumulation is tolerated until it is not — the point at which hepatocytes swell and inflammation begins (ballooning), with scarring behind it. Gut–liver bile-acid signaling and antioxidant induction (NRF2) act across all four.
A liver clearing its own fat changes what the rest of the body sees. Insulin sensitivity and blood-sugar handling improve as the organ stops competing with them; cholesterol, clot formation and reduced clotting move with the export; inflammation, IL-6, inflammatory signaling and monocyte recruitment decide whether stored fat becomes scar. Cellular cleanup, the master antioxidant, eased ER stress and the gut barrier hold the tissue, while alcohol metabolism and acetaldehyde clearance address the other common route to the same picture.
Ten primary pathways of the thirty-two it targets. A pathway opens only on graded, published evidence, shown with its source at the ingredient level.
Educational only. Not evaluated by the FDA.
The story of Fatty Liver Antidote (Hepatic Steatosis Reversal)
Fatty Liver Antidote — ‘The Quiet Undoing’ — for the condition that never knocks. Most things that go wrong in a body announce themselves. Pain. Swelling. A fever. Fat in the liver does none of that (hepatic steatosis). It builds in silence, often for years, in people who feel perfectly well, and it has become one of the most common conditions on earth. It arrives by three roads. Fat pours in from the blood through an intake valve on the liver cell (CD36, fatty-acid uptake). The liver makes new fat of its own from surplus sugar, in a factory that runs hot on a modern diet (fatty-acid synthesis, lipogenesis). And the freighters that should carry fat back out to the rest of the body leave half empty (VLDL export). In, made, not shipped: that is the whole arithmetic of a fatty liver. For a while the liver tolerates it. Then the fat itself becomes the injury. Cells swell with it until their structure gives way (hepatocyte ballooning), inflammation takes hold, and the condition changes its name to something more serious (NASH, when fat turns into damage). Scar begins to replace working tissue (liver fibrosis). Here is the hopeful part: a liver can undo this. Its fuel gauge, the sensor that decides whether to store fuel or burn it, can be turned toward burning (AMPK). Its defense switch can be raised against the oxidants that turn fat into damage (Nrf2). And the bile acids it makes, long taken for mere detergent, turn out to be signals that tell the liver and gut how to handle fuel (bile acid signaling). Fatty Liver Antidote works on every road. The intake valve narrowed. The fat factory slowed. The freighters loaded and sent on their way. The fuel gauge turned toward burning, the defenses raised, and the scar held back. A liver clearing its own fat changes what the rest of the body sees. Energy sensing is the restraint on the factory, and antioxidant defense with the master antioxidant absorbs the cost of running it. Insulin sensitivity and blood-sugar support improve as the organ stops competing with them, cholesterol moves with the export, and fat-burning takes over what synthesis used to claim. Cellular cleanup and eased ER stress hold the tissue while it changes. Clot formation and reduced clotting shift together, because the liver makes the proteins that decide both. Inflammatory signaling and the monocytes it recruits are what settle whether stored fat becomes scar. Alcohol metabolism and acetaldehyde clearance address the other common road to the same picture, while sperm quality and anxiety are where a clearing liver turns up in places nobody thinks to look. The liver built this quietly. Given the chance, it will undo it just as quietly.
Reduces liver fat — the fat inside the liver cell itself, measured the way that fat is measured. Carries the alcohol arm of the disease as well as the metabolic one.
★ 5.0 · 200:1 · $99
The studies, ingredient by ingredient
Across 16 randomized trials in 1,028 people, fatty liver resolved on imaging almost four times as often as on placebo.
Across 26 randomized trials in 2,375 patients, liver fat resolved more than three times as often as on placebo.
In a registered trial, berberine plus lifestyle change cut liver fat by more than half, beyond lifestyle change alone.
In a trial with liver biopsy before and after, 43% improved against 19% on placebo.
In a multinational trial, measured liver fat was lower than on placebo; in long-term animal work, it prevented cirrhosis.
In patients awaiting bariatric surgery, randomized against placebo, measured liver fat fell; three more trials agree.
Sulforaphane switches on the enzyme that clears alcohol's toxic intermediate.
Reishi polysaccharides lowered liver fat in animals through the gut and the antioxidant switch together.
Sixty women with fatty liver, randomized: liver fat and insulin resistance both improved, backed by a fifteen-trial pooled analysis.
Forty-four patients: liver enzymes came down.
Fifty-four patients, randomized against placebo: fatty liver improved with odds better than five to one after weight change was accounted for, and liver stiffness fell while the placebo group grew stiffer.
Randomized against placebo, both liver fat and stiffness improved at the strictest significance level.
A 2024 trial measured liver fat directly on imaging and found it lower.
The shuttle that carries fat into the furnace: four separate pooled analyses agree it improves liver enzymes, blood lipids and insulin resistance.
Nineteen studies and roughly 1,671 people. It drives ammonia into urea and glutamine — and the deficit it corrects is measurable in human liver tissue, where that pathway runs at half speed in proven fatty liver. A multicenter trial improved a quantitative imaging ratio, dose by dose.
In the PREMOTE trial, 409 adults at 20 centers, berberine lowered HbA1c, the long-term blood sugar marker, more than placebo and shifted the bile acids that carry messages between gut and liver.
Alismatis Rhizoma calms the strain inside the liver cell's protein factory — measured in human liver cells and again in animals, with fat accumulation falling alongside.
Three separate blockers were used to try to break the effect, and it held.
Yin Chen Hao, the classical jaundice herb, lowered liver fat and blood lipids together in a fatty-liver model.
Aucklandiae Radix lowers fat inside liver cells through the energy switch and the enzyme that commits fat to storage.
Kudzu's isoflavone daidzin is one of the most selective natural blockers of the enzyme that clears acetaldehyde, which is how it curbs drinking.
Japanese raisin tree, used for hangover for centuries and tested on the alcohol arm.
Four separate preparations converging on the alcohol arm: hepatic cholesterol and triglyceride each fell by roughly a quarter over twelve weeks.
Cordyceps raises the energy switch and the cell's own clearing machinery in fatty liver models.
Dandelion, tested on both roads into the same rooms — the metabolic one and the alcohol one.
Danshen, the most-used liver herb in Chinese medicine: several of its preparations lower liver fat in animals through the energy switch.
A fungus that acts on six separate arms at once — fat storage, the energy switch, cell-factory stress, self-clearance, fat burning and the gut wall.
In genetically obese rats, fenugreek seed significantly lowered the fat stored in the liver, the hallmark of fatty liver.
A methyl donor that keeps the liver's own recycling running — and it is here for that mechanism.
Blocking the energy switch pharmacologically abolished its effect on liver fat.
An apple-peel triterpene tested against a prescription fibrate as the comparator.
Oleanolic acid lowers fat synthesis and raises the energy switch across a clean dose-response.
Tested by putting the problem back: re-supplying the gut toxin it blocks abolished the benefit on two separate readouts.
Turkey tail, with four distinct polysaccharides characterized down to their sugar composition — the deepest structural work behind any mushroom on this.
Polyporus umbellatus's polysaccharides act on the cells that lay down liver scar.
Present in lemon balm, which is the only botanical anywhere with a trial imaging both liver fat and liver stiffness.
The strictest causal test on this.
It calms the strain inside the liver cell's own protein factory.
Raised the energy switch and the cell's self-clearing machinery in rats.
The liver's master antioxidant: after lifestyle counseling came the supplement, and triglycerides, non-esterified fatty acids and ferritin all fell.
Corrected homocysteine against placebo.
Held homocysteine steady across eight weeks — the amino acid whose rise tracks the methylation strain a fatty liver runs under.
One of three vitamins that hold homocysteine down, the amino acid whose rise drives strain inside the liver cell.
Tested head-to-head against milk thistle in a scored biopsy model, it held its own — but no single-herb human trial exists.
On the alcohol side, they raised the enzyme that clears the toxic intermediate — the opposite direction to kudzu here.
Sixteen weeks in a genetically susceptible animal on a high-fat diet: liver fat, liver weight and triglycerides were fully prevented, down to the fine structure of the cell.
In a cell-based reporter test, clove extract switched on TGR5, the bile-acid receptor, an effect the authors traced to its triterpene acids.
These grades describe the maturity of the published science for each ingredient — not a claim that the product treats, cures, or is clinically proven for any goal. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.